Author

Shijie Xu

h-index 0 View on Semantic Scholar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Targeting the Metabolic-Immune Regulator SLC35F6 Enhances Temozolomide and Anti-PD-L1 Therapy in Glioma.

Single-pathway targeted therapy is often insufficient to control malignant glioma progression, and the blood-brain barrier (BBB) remains a major obstacle to effective drug delivery. Therefore, discovering multifunctional target molecules and corresponding drugs that can penetrate the BBB can provide new strategies for...

Peng-Peng Lu, Wei Wang, Bing Lu et al. · Cancer Letters · 0 citations

Open access Aug 2026

DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression

DBF4B holds promise as both a prognostic biomarker and a novel therapeutic target for HCC after functional experiments demonstrated that silencing DBF4B markedly suppressed the proliferative and migratory capabilities of HCC cells.

Bing Dong, Pengju Xi, Guang-Xin Yang et al. · Molecular Biology Reports · 0 citations